Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - LA JOLLA PHARMACEUTICAL COFinancial_Report.xls
10-K - FORM 10-K - LA JOLLA PHARMACEUTICAL COd286951d10k.htm
EX-21.1 - EX-21.1 - LA JOLLA PHARMACEUTICAL COd286951dex211.htm
EX-31.1 - EX-31.1 - LA JOLLA PHARMACEUTICAL COd286951dex311.htm
EX-23.1 - EX-23.1 - LA JOLLA PHARMACEUTICAL COd286951dex231.htm
EX-10.6 - EX-10.6 - LA JOLLA PHARMACEUTICAL COd286951dex106.htm

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, in his capacity as an officer of La Jolla Pharmaceutical Company (the “Registrant”), hereby certifies, for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

   

the annual report of the Registrant on Form 10-K for the year ended December 31, 2011 (the “Report”), which accompanies this certification, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

   

the information contained in the Report fairly presents, in all material respects, the financial condition of the Registrant at the end of such year and the results of operations of the Registrant of such year.

Dated: March 30, 2012

 

/s/ George Tidmarsh

George Tidmarsh
President, Chief Executive Officer and Secretary
(Principal Executive, Financial and Accounting Officer)

Note: A signed original of this written statement required by Section 906 has been provided to La Jolla Pharmaceutical Company and will be retained by La Jolla Pharmaceutical Company and furnished to the Securities and Exchange Commission or its staff upon request.